The University of Nairobi ‘ACTION’ Trial team held a one day meeting with the study staff from all the participating hospitals
Printer-friendly versionPDF version
Location / Venue: 

College of Health Sciences(CHS), University of Nairobi

The WHO ACTION trial held mid-term review meeting on 9th July, 2019 at the UNITID seminar room to assess the progress of the study in Kenya.

The WHO ACTION Trial is  a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent preterm birth in health facilities in low-resource settings. The trials’ aim is to determine whether antenatal corticosteroids are safe and efficacious for women at risk of imminent birth in early and late preterm periods in health facilities in low-resource settings, and lead to improved newborn outcomes. ACTION I trial has been ongoing in our 4 Kenyan sites (Kiambu, Thika, Mombasa, Nakuru) since October 2018.


Expiry Date: 
Fri, 2021-07-16 (All day)